Announcements Trials
Browse Landscape

Status

Completed 8

Sponsor Class

INDUSTRY 5OTHER 3

Study Type

Interventional 149Observational 8

Sponsor

Cancer Type

Genitourinary 7Sarcoma 1

Conditions

Carcinoma, Renal Cell 7Financial Stress 2Sarcoma 1Coronary Artery Disease 1

Interventions

Surveys and Questionnaires 286Blood Specimen Collection 145Gene Expression Profiling 96Interviews as Topic 83Immunohistochemistry 78Polymerase Chain Reaction 64Surgical Procedures, Operative 62Magnetic Resonance Spectroscopy 58Microarray Analysis 55Flow Cytometry 53Radiotherapy 49Amplified Fragment Length Polymorphism Analysis 48Drug Therapy 46Observation 45Biopsy 42Reverse Transcriptase Polymerase Chain Reaction 39Bevacizumab 39Data Collection 35Sorafenib 29Psychiatric Rehabilitation 29Nivolumab 28palbociclib 26In Situ Hybridization, Fluorescence 26Rituximab 25Therapeutics 24Neoadjuvant Therapy 24Hepatectomy 24Docetaxel 24Colonoscopy 24Sunitinib 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Completed × Observational × pazopanib × Clear all
NCT02184416 2026-02-27

ADONIS

Pfizer

Completed
554 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT01649778 2020-07-15

PRINCIPAL

Novartis

Completed
662 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT03519542 2019-09-18

SOGANG

Spanish Oncology Genito-Urinary Group

Completed
62 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT02282579 2018-04-26

SPAZO

Spanish Oncology Genito-Urinary Group

Completed
300 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT01995981 2017-12-19

PREDICT

Radboud University Medical Center

Completed
22 enrolled
Sarcoma

Sarcoma

NCT01446224 2015-03-27

Cardiovascular and Torsades de Pointes Monitoring for Pazopanib

GlaxoSmithKline

Completed
1 enrolled
Genitourinary

Carcinoma, Renal Cell, Coronary Artery Disease

NCT01381601 2013-05-13

Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (Pharmetrics)

GlaxoSmithKline

Completed
1 enrolled
Genitourinary

Financial Stress, Carcinoma, Renal Cell

NCT01381614 2013-05-13

Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (IHCIS)

GlaxoSmithKline

Completed
1 enrolled
Genitourinary

Financial Stress, Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡